| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Elizabeth Varki Jobes is Director at BLFY. Elizabeth Varki Jobes's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Elizabeth Varki Jobes has 4 Form 4 filings on record from March 2022 to March 2026, across 2 companies: Director at Blue Foundry Bancorp (BLFY), 2023–2026; Director at Ampio Pharmaceuticals (AMPE), 2022.
The 7 reported transactions were 2 dispositions back to the company, 2 option or other derivative awards, 2 open-market purchases and 1 stock award.
Counted by filing, the open-market trades come to 1 purchase worth about $20K and no sales.
The only open-market purchase was 2,247 shares of BLFY at an average $8.90 on May 17, 2023, about $20K. Twelve months later BLFY was up 4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | BLFY Blue Foundry Bancorp | Director | Buy | 2,247 | $8.90 | $19,997.41 | New | +5.7% | +4.3% |